Danica Kirka
London
About Danica Kirka
Covering money and power for the Associated Press in London
Zaghari-Ratcliffe, Ashoori return to Britain after Iran deal
Two British citizens who had been jailed in Iran for more than five years — charity worker Nazanin Zaghari-Ratcliffe and retired civil engineer Anoosheh Ashoori — returned home to their families' hugs and tears on Thursday, March 16, 2022, after the U.K. settled a decades-old debt to Iran.
Shell will stop buying Russian oil, natural gas
Energy giant Shell said on Tuesday, March 8, 2022, that it will stop buying Russian oil and natural gas and shut down its service stations, aviation fuels and other operations in the country amid international pressure for companies to sever ties over the invasion of Ukraine.
"Major cities really matter": Mayors from cities across the world demand climate action
On a train hurtling toward Glasgow, the mayors of Seattle and Freetown, Sierra Leone, greeted each other like long lost sisters, bonded by years of Zoom calls and collaboration in the fight against climate change.
As COVID cases rise, some activists fearful of climate talks
Climate activist Lavetanalagi Seru has been watching COVID-19 case numbers rise in the U.K. ahead of the U.N. climate conference beginning on Sunday, October 31, 2021, and it scares him — even though he’s been vaccinated and is only 29.
COP26 climate talks should be postponed because of COVID risk: environmental groups
A coalition of environmental groups called on Tuesday, September 7, 2021, for this year’s climate summit to be postponed, arguing that too little has been done to ensure the safety of participants amid the continuing threat from COVID-19.
Shell outlines plan for steady decrease in oil business
Royal Dutch Shell, one of the multinationals that has defined the oil industry, is slowly turning away from the fossil fuel that made its fortune over the decades but also worsened a global climate crisis.
Cheap, easy-to-store COVID-19 vaccine proves effective in late-stage trials, drugmaker says
Drugmaker AstraZeneca said Monday that late-stage trials showed its COVID-19 vaccine is highly effective, buoying the prospects of a relatively cheap, easy-to-store product that may become the vaccine of choice for the developing world.